Marie Havenga is a veteran journalist of more than 30 years. The Grand Rapids native launched her journalism career at age 15, writing for WorkWeek, a weekly business magazine. She joined the Grand Haven Tribune staff as a columnist and reporter in 2003, after writing for the Grand Rapids Press for more than two decades. A boating and water enthusiast, she lives on the shores of Spring Lake. Havenga has published an environmental children's book and her writing has been featured in several national publications.
Not long ago, teenager Madisyn Dame would have been too young for hip surgery. Medical advancements have allowed her to undergo two of them—with incredible results.
Alison Mastin's blood attacked her unborn baby in utero. With quick intervention, little Violet survived—and thrived.
After battling back from a devastating brain injury suffered in a car crash, this young man walks side-by-side with his mom as he stakes claim to a new life.
The average age for pancreatic cancer diagnosis is 71. John Morris hit it on the nail. But now, he's defying the odds.
Hope Looyenga plans for a bright, cancer-free future.
He died of a rare bone cancer in 2016, but continues to make a difference through a tissue donation that is helping researchers battle osteosarcoma.
Born blind, a 14-year-old boy has become a virtuoso who sees colors within the most intricate sounds of music.
David Stults developed popcorn lung after exposure to dangerous food chemicals. He's now hitting the school circuit to teach students the dangers of vaping similar substances.
Hockey player and taxidermist Chad Kious envisions his return to the ice after having a unique surgery to remove the blood clot in his brain.
Becky Powers tried for five years to get pregnant. She finally did, but the swine flu nearly killed her and her unborn baby.
Through pregnancy, an emergency C-section, pediatric appointments and a broken bone, MyChart has been a trusted companion for this family.
When stomachaches turned out to be the worst form of pancreatic cancer, Tricia Johnson found hope in a targeted clinical trial treatment.
